You can buy or sell Merck and other stocks, options, ETFs, and crypto commission-free!
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Read More The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
Kenilworth, New Jersey
52 Week High
52 Week Low
Eisai and Merck Receive Complete Response Letter for LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma
Eisai Co., Ltd. Public Relations: +81-(0)3-3817-5120 Merck & Co., Inc., Kenilworth, N.J., U.S.A. Media Relations Pamela Eisele: (267) 305-3558 Michael Close: (2
BRIEF-Zymeworks & Merck Sign New License Agreement
July 8 (Reuters) - Merck & Co Inc: * ZYMEWORKS - CO & MERCK SIGNED NEW LICENSE AGREEMENT * ZYMEWORKS - AGREEMENT GRANTS MERCK RIGHT TO DEVELOP ADDITIONAL MULT
— per share
Available Jul 31, Pre-Market